Atopic dermatitis (AD) has long been recognized as a common, chronic inflammatory skin disease. However, an expanding body of scientific evidence, coupled with a deeper understanding of the immunopathologic mechanisms underscoring AD development, suggest that it should be recognized and treated as a systemic disorder. Evidence implies the involvement of systemic immunologic activation in the modification of the skin barrier, consequentially affecting non-lesioned skin in a subclinical, histologically distinct manner. Because of the common misconception that AD is a limited, site-specific skin disease, patients are often mistreated with excessive corticosteroids, multiple confusing topical treatment regimens, or undertreated altogether. Additionally, recent advances in the systemic management of AD have added a new level of complexity to the clinical scene.

The CME-accredited educational curricula provided here by RMEI Medical Education, LLC are designed to engage practicing clinicians with actionable insights for improving the delivery of patient care. Some of the world’s foremost clinical experts on atopic dermatitis are featured as faculty, in video and audio dialogues, with real patients. New activities and live meetings are added regularly, so be sure to check back for updates!

Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis

A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular history and ...

Read more:

Combining Biologics in a Young Patient with Atopic Dermatitis

Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases. ...

Read more:

Options for an Infant with Atopic Dermatitis

Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel discusses how th...

Read more:

Advances in the Management of Moderate-to-Severe Atopic Dermatitis

This multidisciplinary faculty panel and a patient deliberate over challenging topics in moderate-to-severe atopic dermatitis. ...

Read more:

Clinical Conversations: The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients

In this activity, our patients Karen and Alex share their histories, field their questions, concerns, and demonstrate their thought process while engaged in the treatment decision-making process. ...

Read more:

Clinical Reflections®: The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients

This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient care to allow you to rethink clinical decisions based on the scenarios presented, and to modify treatment plans accordingly. Yo...

Read more:

Clinical Convergence®: The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients

This activity features 2 patient cases, challenging interactive questions related to the cases, and video vignettes. You will have an opportunity to hear from our expert faculty and learn from the patients’ perspectives. ...

Read more: